======= BDH2 =======
== Gene Information ==
* **Official Symbol**: BDH2
* **Official Name**: 3-hydroxybutyrate dehydrogenase 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=56898|56898]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9BUT1|Q9BUT1]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=BDH2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20BDH2|Open PubMed]]
* **OMIM**: N/A
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Dehydrogenase that mediates the formation of 2,5- dihydroxybenzoic acid (2,5-DHBA), a siderophore that shares structural similarities with bacterial enterobactin and associates with LCN2, thereby playing a key role in iron homeostasis and transport. Also acts as a 3-hydroxybutyrate dehydrogenase (By similarity). {ECO:0000250, ECO:0000269|PubMed:16380372}.
|adh short|
|siderophore biosynthetic process|
|siderophore metabolic process|
|3-hydroxybutyrate dehydrogenase activity|
|oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor|
|ketone body biosynthetic process|
|cellular ketone body metabolic process|
|ketone body metabolic process|
|nonribosomal peptide biosynthetic process|
|secondary metabolite biosynthetic process|
|heme metabolic process|
|porphyrin-containing compound metabolic process|
|NAD binding|
|secondary metabolic process|
|fatty acid beta-oxidation|
|tetrapyrrole metabolic process|
|pigment metabolic process|
|fatty acid oxidation|
|lipid oxidation|
|iron ion homeostasis|
|fatty acid derivative biosynthetic process|
|fatty acid catabolic process|
|monocarboxylic acid catabolic process|
|transition metal ion homeostasis|
|fatty acid derivative metabolic process|
|cellular lipid catabolic process|
|lipid modification|
|cofactor biosynthetic process|
|organic acid catabolic process|
|carboxylic acid catabolic process|
|lipid catabolic process|
|fatty acid metabolic process|
|peptide biosynthetic process|
|generation of precursor metabolites and energy|
|small molecule catabolic process|
|cofactor metabolic process|
|drug metabolic process|
|amide biosynthetic process|
|peptide metabolic process|
|monocarboxylic acid metabolic process|
|small molecule biosynthetic process|
|metal ion homeostasis|
|epithelial cell differentiation|
|cation homeostasis|
|inorganic ion homeostasis|
|ion homeostasis|
|cellular amide metabolic process|
|carboxylic acid metabolic process|
|cellular lipid metabolic process|
|oxidation-reduction process|
|oxoacid metabolic process|
|organic acid metabolic process|
|chemical homeostasis|
|epithelium development|
|lipid metabolic process|
|mitochondrion|
|organonitrogen compound biosynthetic process|
|cellular nitrogen compound biosynthetic process|
|homeostatic process|
|small molecule metabolic process|
|tissue development|
|organic substance catabolic process|
|cellular catabolic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp472|CI-1040 9.5μM R08 exp472]]|-1.71|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 13909
* **Expression level (log2 read counts)**: 5.18
{{:chemogenomics:nalm6 dist.png?nolink |}}